FDA and GxP expectations
Risk-based decision-making is central to FDA and GxP expectations. We provide risk assessments for processes, systems, studies/programs, and vendors to help organizations identify vulnerabilities early and document mitigation strategies.
Our approach prioritizes practical actions and defensible documentation, ensuring risk decisions can be explained clearly during audits and inspections.
Typical Deliverables
- Risk assessment report or summary
- Risk register (as applicable)
- Mitigation plan and prioritization approach
- Documentation templates for ongoing risk review
Outcomes/Benefits
- Proactive issue prevention
- Clear prioritization of compliance efforts
- Improved readiness for audits and inspections
- Better documented, risk-based decisions